IndiaTickerCertificate under SEBI (Depositories and Participants) Regulations, 2018 - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Company dossier
Gufic BioSciences
NSE:GUFICBIO · ISIN INE742B01025
- Close
- ₹382.35 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gufic BioSciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Trading Window - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Gufic Biosciences Ltd - 509079 - Corrigendum And Clarification To Intimation Dated May 29, 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank LimitedBSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Corrigendum And Clarification To Intimation Dated May 29, 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank LimitedBSE · exchange filing · pdf
Source filing General Updates - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing General Updates - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gufic Biosciences LimitedNSE · conference call · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Results - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Gufic Biosciences Ltd - 509079 - Board Meeting Outcome for Meeting Held On Friday, May 29, 2026BSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Gufic Biosciences LimitedNSE · financial results · pdf
Source filing Dividend - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Gufic Biosciences LimitedNSE · financial results · pdf
Source filing Change in Auditors - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Acquisition - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gufic Biosciences LimitedNSE · conference call · pdf
Source filing Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31, 2026 And To Recommend A Final Dividend, If Any, For The Financial Year 2025-26BSE · financial results · pdf
Source filing Gufic Biosciences Ltd - 509079 - Update On Further Investment In Selvax Pty Ltd.BSE · exchange filing · pdf
Source filing General Updates - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Gufic Biosciences LimitedNSE · exchange filing · pdf
Source filing